← Clinical Evidence

SRC-88decc5d5802 Bowman 2018

Evidence source and scope

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1186/s40945-018-0051-2

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Bowman, Thomas; Gervasoni, Elisa; Parelli, Riccardo et al. Predictors of mobility domain of health-related quality of life after rehabilitation in Parkinson's disease: a pilot study. Archives of physiotherapy. 2018. DOI 10.1186/s40945-018-0051-2

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — balance

Latest listed audit check, current for its stated components. Later recovery/refinement here supersedes earlier access limitations only where explicitly stated; it does not resolve unrelated source contradictions.

Balance P228 and P297–299: all specified N, sessions and correlations confirmed. Results continuation confirms five post-treatment dropouts, 37 complete cases, and sex, Hoehn–Yahr stage and baseline PDQ-mobility as selected predictors. Baseline Berg was not a predictor of change. Source locator: Primary body s3–4; s7 Table 2; s8 Tables 4–5 and Results continuation Limit: Small treatment cohort; no treatment-effect interaction or external validation.

Earlier audit check 1 (historical evidence record). Its access limitations are superseded wherever the latest check above explicitly closes them. Retained for the distinct components and provenance, not as a current access statement.

BalanceP228/P297-299:42recruited20sessions45min3/week;BBSbaselinePDQmobilityr-.40p.009;BBSvschange-.06p.70;ABCvschange.09p.58;noexternalvalidationortreatmentinteraction;baseline/changeassociationdistinct. Source locator: s3Subjects;s4ClinicalAssessment;s7Table2;s8Table4 Limit: 37posttreatmentmodelandselectedsex/HY/baselinePDQvariables require modelResultscontinuation;notyetchecked in thisentry.

Limitations: Only scoped comparisons, not whole-paper certification.

Parkinson’s disease — balance1

Latest listed audit check, current for its stated components. Later recovery/refinement here supersedes earlier access limitations only where explicitly stated; it does not resolve unrelated source contradictions.

Balance P228 and P297–299: all specified N, sessions and correlations confirmed. Results continuation confirms five post-treatment dropouts, 37 complete cases, and sex, Hoehn–Yahr stage and baseline PDQ-mobility as selected predictors. Baseline Berg was not a predictor of change. Source locator: Primary body s3–4; s7 Table 2; s8 Tables 4–5 and Results continuation Limit: Small treatment cohort; no treatment-effect interaction or external validation.

Earlier audit check 1 (historical evidence record). Its access limitations are superseded wherever the latest check above explicitly closes them. Retained for the distinct components and provenance, not as a current access statement.

BalanceP228/P297-299:42recruited20sessions45min3/week;BBSbaselinePDQmobilityr-.40p.009;BBSvschange-.06p.70;ABCvschange.09p.58;noexternalvalidationortreatmentinteraction;baseline/changeassociationdistinct. Source locator: s3Subjects;s4ClinicalAssessment;s7Table2;s8Table4 Limit: 37posttreatmentmodelandselectedsex/HY/baselinePDQvariables require modelResultscontinuation;notyetchecked in thisentry.

Limitations: Only scoped comparisons, not whole-paper certification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide